Leaderboards/Neurological diseases and metabolism

Neurological diseases and metabolism

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Sofia Lövestam
MRC Laboratory of Molecular Biology
2
Giuseppe Mario Bentivenga
University of Bologna
3
Sophie Dithmer
Leibniz-Forschungsinstitut für Molekulare Pharmakologie
4
Paras Mani Giri
North Dakota State University
5
Dylan V. Neel
Harvard University
6
Andrew Chang
Columbia University
7
Aimee Rachel Mathew
Sapienza University of Rome
8
Nanshan Song
Nanjing University of Chinese Medicine
9
Paul J. Hop
Utrecht University
10
Kristina Ibáñez
Queen Mary University of London

Papers

1
Publication in International Journal of Molecular Sciences (2024) [97 citations, W4398222588]
International Journal of Molecular Sciences|2024
97 cit.
2
Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden
Acta Neuropathologica|2024
94 cit.
3
Publication in International Journal of Molecular Sciences (2024) [91 citations, W4393896893]
International Journal of Molecular Sciences|2024
91 cit.
4
Vitamin B12 Deficiency and the Nervous System: Beyond Metabolic Decompensation—Comparing Biological Models and Gaining New Insights into Molecular and Cellular Mechanisms
International Journal of Molecular Sciences|2024
81 cit.
5
Publication in Translational Neurodegeneration (2024) [78 citations, W4394887840]
Translational Neurodegeneration|2024
78 cit.
6
Increased frequency of repeat expansion mutations across different populations
Nature Medicine|2024
72 cit.
7
Clinical value of novel blood‐based tau biomarkers in Creutzfeldt–Jakob disease
Alzheimer s & Dementia|2024
19 cit.
8
Multicenter expanded access program for access to investigational products for amyotrophic lateral sclerosis
Muscle & Nerve|2024
10 cit.
9
Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt–Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia
International Journal of Molecular Sciences|2024
8 cit.
10
Publication in Biomedicine & Pharmacotherapy (2024) [8 citations, W4396950476]
Biomedicine & Pharmacotherapy|2024
8 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Elisa Majounie
Illumina (United States)
2
Diana Arseni
MRC Laboratory of Molecular Biology
3
Benjamin Falcon
MRC Laboratory of Molecular Biology
4
S. S. Scherer
University of Toronto
5
Esther Sammler
University of Dundee
6
Joel C. Watts
University of Toronto
7
Lin Jiang
China Agricultural University
8
Jinchen Li
Central South University
9
Sonia M. Vallabh
Broad Institute
10
Juliane Winkelmann
Helmholtz Zentrum München

Papers

1
TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
Nature|2023
162 cit.
2
Heteromeric amyloid filaments of ANXA11 and TDP-43 in FTLD-TDP type C
Nature|2024
78 cit.
3
Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease
Nature Neuroscience|2024
75 cit.
4
TAF15 amyloid filaments in frontotemporal lobar degeneration
Nature|2023
52 cit.
5
Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease
npj Parkinson s Disease|2023
37 cit.
6
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson’s disease
Acta Neuropathologica Communications|2023
26 cit.
7
VarCards2: an integrated genetic and clinical database for ACMG-AMP variant-interpretation guidelines in the human whole genome
Nucleic Acids Research|2023
24 cit.
8
Performance Comparison of Computational Methods for the Prediction of the Function and Pathogenicity of Non-Coding Variants
Genomics Proteomics & Bioinformatics|2022
23 cit.
9
A single protective polymorphism in the prion protein blocks <scp>cross‐species</scp> prion replication in cultured cells
Journal of Neurochemistry|2022
17 cit.
10
Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease
Journal of Virology|2023
17 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Stanley B. Prusiner
University of California, San Francisco
2
Virginia M.‐Y. Lee
Institute for Neurodegenerative Disorders
3
Susan Lindquist
Howard Hughes Medical Institute
4
John Collinge
National Health Service
5
Thomas Gasser
Hertie Institute for Clinical Brain Research
6
Michel Goedert
MRC Laboratory of Molecular Biology
7
Bryan J. Traynor
National Institutes of Health
8
J. Timothy Greenamyre
University of Pittsburgh
9
Andrew Singleton
Short and Associates (United States)
10
Nicholas Wood
National Hospital for Neurology and Neurosurgery

Papers

1
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Science|2006
6.6k cit.
2
Novel Proteinaceous Infectious Particles Cause Scrapie
Science|1982
5.1k cit.
3
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Neuron|2011
4.5k cit.
4
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Nature Neuroscience|2000
3.7k cit.
5
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in <i>PINK1</i>
Science|2004
3.5k cit.
6
α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies
Proceedings of the National Academy of Sciences|1998
3.2k cit.
7
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Neuron|2004
3.1k cit.
8
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Science|2012
2.6k cit.
9
Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease
Neuron|1989
2.5k cit.
10
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Neuron|2004
2.4k cit.

Reagents for Neurological diseases and metabolism

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 67

COL3A1 Antibody

Cited in 7 papers
#30565$317
View Evidence →
Cell Signaling Technology

PYURF (F9F4X) Rabbit Monoclonal Antibody

Cited in 7 papers
#16847$161,376
View Evidence →
Cell Signaling TechnologyEvidence 65

SARM1 (D2M5I) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 6 papers
#32629$865
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

p130 Cas (E1L9G) Rabbit Monoclonal Antibody

Cited in 17 papers
#13383$161,351
View Evidence →
Cell Signaling TechnologyEvidence 64

CD74 (F6K1S) Rabbit Monoclonal Antibody

Cited in 8 papers
#70167$161,376
View Evidence →
Cell Signaling Technology

FAT1 Antibody

Cited in 7 papers
#10962$320
View Evidence →